AF
PFE icon

Amalgamated Financial’s Pfizer PFE Stock Holding History

Amalgamated Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$76.7M Buy
+1,482,472
New +$76.9M 0.61% 19

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Amalgamated Financial's PFE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Pfizer (PFE) in Q1 2022: 1,482,472 shares worth $76.7M. The stake represents 0.61% of the portfolio and ranks #19 among its holdings.

3,196 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Amalgamated Financial held 1,482,472 shares of Pfizer worth $76.7M as of Q1 2022.
  • Pfizer was a new Amalgamated Financial position in Q1 2022.
  • Pfizer made up 0.61% of Amalgamated Financial's portfolio in Q1 2022, its #19 holding.
  • 3,196 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.